Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes
about
Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodiesInfectious diseases associated with complement deficiencies.Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophilsIndependent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06.Genetic diversity and carriage dynamics of Neisseria lactamica in infantsVariation in the Neisseria lactamica porin, and its relationship to meningococcal PorBThe oligosaccharide of gonococcal lipooligosaccharide contains several epitopes that are recognized by human antibodies.Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers.Analysis of lipooligosaccharide biosynthesis in the Neisseriaceae.Neisseria lactamica protects against experimental meningococcal infection.Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions.Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing.Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraoseHuman natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfacesHuman lipooligosaccharide IGG that prevents endemic meningococcal disease recognizes an internal lacto-N-neotetraose structure.Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes.Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae.Carriage of Neisseria species in communities with different rates of meningococcal disease.Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis.Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity.In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.Current status of meningococcal group B vaccine candidates: capsular or noncapsular?Further antigenic similarities of Neisseria gonorrhoeae lipooligosaccharides and human glycosphingolipids.Enzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS.Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.Immunophysical characterization of human isolates of Serratia marcescens.Acquisition of the capsule locus by horizontal gene transfer in Neisseria meningitidis is often accompanied by the loss of UDP-GalNAc synthesis.Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide.Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate.Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function.
P2860
Q28378767-75AD32B4-E09A-4791-A1B1-A4BE4D2EA4A8Q30450183-6BB2D7F8-6A0D-42EF-B935-192031E3A7FAQ33751449-E8F872EF-9EC2-47E6-A6EA-B9B54C11F622Q33752108-CA369AF0-AC57-4B25-9CC4-EDD85EFAB1D0Q33769344-DA71A90A-3BCE-44D9-804B-8027C921E0B7Q33913053-C9A2DC0E-474C-46D5-A29D-63443CBCDC85Q33963027-32A68A25-2600-4272-96CB-F88DEBD255CAQ33972168-BE0B34CF-14FB-48AC-AB63-A4222FE8B962Q33995459-8020B4B9-34F2-4282-AA48-DB8F559C407AQ34126031-4B51B740-2F03-4EB8-8BF3-C8950B1BFF10Q35217627-0CB24679-88C0-45E8-8C58-7C4F552AB679Q35224124-FDA1201B-3A85-4817-8A77-BA60D53EBBA4Q35458135-C4044087-0DC7-4CFC-9135-D2769A48D727Q35557535-A56D604B-32F0-4943-BAE7-81D57C24F00AQ35600711-7A56F37E-F07E-4E2D-9E39-FBE904B4F6C3Q35626087-15048C03-9D1F-4641-98E2-E14E24CC0BB1Q35778475-0BC57257-04EA-4804-BBD0-075739F44324Q35779576-C65C0157-6EF8-4923-9C30-E36C4714EE1BQ35893225-AF48E331-2CC4-4AE6-9A88-DFFA8DEED4E1Q36145701-0F64D5FE-44B6-4938-80DC-2FBD5D64882CQ36227890-BB301DFC-5DB2-4B16-8F58-FE334514FED2Q36351128-47202DB2-470E-4F8B-B269-F7E33116C6EAQ36642138-45B812CB-94E8-4D46-9075-F71AF6492622Q36948322-8958B71F-153A-402F-B838-9804D74DFB7FQ36964293-FEFDE3AB-8CE8-4694-A39F-A9C13FA9E60EQ37058833-F3FF9FEF-459F-41B2-8FE9-7222A4E0B249Q37125206-CEE1C694-6F3D-4772-A44D-E7EC90121F65Q37224732-ED948AFB-986B-4A9E-82BE-4A370B8EA5E0Q37698801-54BB96B4-787B-4421-A2E9-E940538EB1F4Q38340301-04D085A6-7D81-4D7A-BE83-6F64606D0083Q40148728-7F5626DF-6E36-4665-9656-8E0B85C5240EQ42413093-AB008AE0-AB02-42AD-A329-38D868171961
P2860
Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Neisseria lactamica and Neisse ...... s 1, 2, and 3 protein epitopes
@ast
Neisseria lactamica and Neisse ...... s 1, 2, and 3 protein epitopes
@en
type
label
Neisseria lactamica and Neisse ...... s 1, 2, and 3 protein epitopes
@ast
Neisseria lactamica and Neisse ...... s 1, 2, and 3 protein epitopes
@en
prefLabel
Neisseria lactamica and Neisse ...... s 1, 2, and 3 protein epitopes
@ast
Neisseria lactamica and Neisse ...... s 1, 2, and 3 protein epitopes
@en
P2093
P2860
P1476
Neisseria lactamica and Neisse ...... s 1, 2, and 3 protein epitopes
@en
P2093
J M Griffiss
R E Mandrell
P2860
P304
P407
P577
1989-02-01T00:00:00Z